Global 
Sverige 
USA Stille launches imagiQ3™ at RSNA 2024
Stille AB (publ) proudly unveils the imagiQ3™, the next generation of C-arm tables, designed to set new standards in visualization, operating room efficiency and patient safety.
Stille is proud to announce the launch of imagiQ3™, the next generation of advanced C-arm tables. With a commitment to product leadership and innovation, the new table is designed for ultimate visualization and OR efficiency combined with minimized radiation exposure to surgeons, OR staff and patients.
“The launch of imagiQ3™ is a major step in growing our surgical table business and in our commitment to supporting surgeons, OR staff and patients with advanced C-arm tables.” says Torbjörn Sköld, CEO. “The imagiQ3™ Legacy is the first table in our third generation of imagiQ™ and will serve as the foundation for future product developments and enhancements.”
The imagiQ3™ Legacy builds on the successful heritage of previous generations with a highly radiolucent table top, the legendary True Free Float™ technology and a sleek, slim design ensuring optimal visibility and access during procedures. Designed with the evolving needs of surgeons, OR staff and patients in mind, the new C-arm table combines the trusted features of imagiQ2™ with a completely new technological platform, delivering enhanced performance for healthcare professionals.
imagiQ3™ Legacy’s virtuous design reflects market needs of enhanced precision, ease of use, sustainability and durability. The imagiQ3™ Service Integration feature helps to assist in off-site troubleshooting, allowing Stille’s technicians to remotely diagnose potential issues.
“The imagiQ3™ Service Integration is an innovative technology, which reduces downtime and costly onsite diagnoses and repairs.” explains Ralph Tamm, Product Director.
The imagiQ3™ Legacy aligns with Stille’s strategy of product leadership in advanced C-arm tables. By prioritizing quality, innovation, user-centric design and sustainability, Stille continues to set the standard for surgical solutions.
The product launch will start in the U.S., Europe and Japan in the coming weeks, supported by approvals from both the U.S. Food and Drug Administration (FDA) 510k exempt and CE Mark.
The imagiQ3™ Legacy will be presented for the first time at RSNA, Chicago, IL, U.S. on December 1st, North Hall Level 3, #7944.
Torshälla, November 25th, 2024.
